Meaningful endpoints for therapies approved for hematologic malignancies
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30622
Abstract: Overall survival (OS) is considered the gold standard for determining treatment efficacy in oncology trials, but the relation between treatment and OS can be challenging to assess because of long study durations and the impact… read more here.
Keywords: endpoints therapies; approved hematologic; therapies approved; hematologic malignancies ... See more keywords